Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AZ.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AZ.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.114EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.114EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.114ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.114ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.114EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.114EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.114ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.114ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.39ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.39ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.39EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.39EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.199EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.199EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.199ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.199ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.199EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.199EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.199ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.199ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3870.9South Korea
B.1.1.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.1.74ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
B.1.1.74ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.1.74EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
B.1.1.74EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.1.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.406EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.406EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.406ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.406ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.406EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.406EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.406ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.115EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.115EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.115ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.115ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.115EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.115EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used